Decision to list medical devices supplied by Stryker New Zealand Limited
We are pleased to announce the approval of a listing agreement for the supply of medical devices to Te Whatu Ora hospitals.
What we’re doing
We are pleased to announce the approval of a listing agreement for the supply of medical devices to Te Whatu Ora Hospitals supplied by Stryker New Zealand Limited (“Stryker”):
In summary this will result in:
- Stryker’s medical devices in the above categories being listed in Part III of Section H of the Pharmaceutical Schedule from 1 September 2023 under a national agreement that all Te Whatu Ora hospitals may purchase under; and
- Te Whatu Ora hospitals being able to purchase other suppliers’ brands of medical devices from the above categories as the agreement is not for sole supply.
Any changes to the original proposal?
Minor changes to the product list have been made following consultation to correct administrative errors such as duplicates and inaccurate branding information.
Who we think will be most interested
- Te Whatu Ora Hospital staff including but not limited to:
- ICU, emergency, and critical care staff
- Neurologists and Neurosurgeons
- Perioperative staff
- Sterile services personnel
- Surgical and general ward staff
- Clinical engineers and maintenance services
- Procurement and supply chain
- Suppliers and wholesalers
Details about this decision
In 2021 Pharmac released a Request for Proposals (“RFP”) for
The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
After completing the evaluation process, and consulting on the provisional agreement with Paragon, Pharmac has decided to list Paragon’s surgical implants, and medical and surgical instruments and power tools in Part III of Section H of the Pharmaceutical Schedule from 1 September 2023.
Te Whatu Ora Hospitals can continue to choose which surgical implants, medical and surgical instruments and power tools they procure, including those from other suppliers. Te Whatu Ora Hospitals that procure these medical devices from Paragon must do so under the terms and conditions, including pricing, in the agreement from 1 September 2023.
Our response to what you told us
We’re really grateful for the time people took to respond to this consultation.
A summary of the main themes raised in feedback and our responses to the feedback received are set out below.
Queries on general and detailed provisions for instrument and equipment management and access.
The agreement includes terms and conditions associated with instrument and equipment management.
Pharmac will continue to work with Te Whatu Ora to understand their equipment management requirements and ensure agreement terms are practical for all parties. Pharmac views the current arrangements as fit for purpose and that no further changes are required as a result of consultation.
If you have any questions about this decision, you can email us at firstname.lastname@example.org; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.